PAXLOVID

Indicated For

COVID-19

About This Medication

# PAXLOVID Patient Assistance Program Guide: Getting Treatment at Low Cost ## What is PAXLOVID? PAXLOVID (nirmatrelvir/ritonavir) is an antiviral medication made by Pfizer that treats COVID-19. It works best when started within 5 days of symptom onset. If cost is a barrier to getting this medication, Pfizer's patient assistance program can help. ## Who Can Apply? The US Government Patient Assistance Program for PAXLOVID is available to patients with specific insurance types or no insurance. **Commercially insured patients are not eligible** for this program—talk to your insurance company about coverage instead. ### Eligible Insurance Types: - Medicare - Medicaid - TRICARE - VA Community Care Network - Uninsured patients ### Income Requirements Income limits vary by family size and state. Generally, the program serves patients at or near federal poverty levels, though exact thresholds differ. During the application process, you'll learn if your income qualifies. There is **no income limit for Medicare patients**—if you have Medicare, you're automatically eligible regardless of income. ## What You'll Need to Apply Gather these three documents before applying: 1. **Valid Prescription** – A prescription from a US-licensed healthcare provider for PAXLOVID 2. **Proof of Income** – Recent tax return, pay stubs, W-2 form, or benefit statements (last 30-60 days) 3. **Proof of Residency** – Utility bill, lease agreement, or government-issued ID showing your current US address ## How to Apply: 4 Steps **Step 1: Visit the Program Website** Go to https://www.paxlovid.com/paxcess to start your application. **Step 2: Provide Your Information** Enter your personal details, insurance type, income information, and residency proof. The application takes about 15-20 minutes. **Step 3: Submit Your Documents** Upload or mail copies of your prescription, income verification, and proof of residency. You can apply online, by phone, or by mail. **Step 4: Wait for Approval** Pfizer will review your application and contact you with a decision. Once approved, you'll receive information on how to access your medication at no cost or low cost. ## Contact Information **Phone:** (877) 219-7225 **Website:** https://www.paxlovid.com/paxcess Call this number if you have questions about eligibility, need help with your application, or want to apply by phone instead of online. ## Timeline: When Will I Get My Medication? Most applications are reviewed within **3-5 business days**. Once approved, you can pick up PAXLOVID at your pharmacy immediately or have it shipped to you. Because COVID-19 treatment is time-sensitive, apply as soon as you receive your prescription. ## Savings Card Option If you don't qualify for the full patient assistance program or have commercial insurance, ask your pharmacy about Pfizer's PAXLOVID savings card. This discount program may reduce your out-of-pocket costs. ## Important Notes - **No Reauthorization Required:** Once approved, you won't need to reapply for the same prescription. - **Biosimilars:** There are no generic or biosimilar versions of PAXLOVID at this time. - **Privacy Protected:** Your application information is kept confidential and protected by federal privacy laws. ## What If I'm Denied? If your application is denied, ask why. Common reasons include: - Income exceeds program limits - Insurance type is not eligible - Missing documents You can reapply if your situation changes. Also explore whether your insurance company offers coverage or if other assistance programs apply to you. ## Still Have Questions? Call the program at (877) 219-7225 Monday through Friday, 9 AM to 9 PM ET. A representative can answer eligibility questions, help you apply, or explain denial reasons. ## Next Steps 1. Confirm you have a valid prescription for PAXLOVID 2. Check your insurance type against the eligible list 3. Gather your income and residency documents 4. Apply online at https://www.paxlovid.com/paxcess or call (877) 219-7225 5. Follow up on your application status within one week if you haven't heard back

Program information last verified: March 25, 2026